Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Polidocanol Foam vs HAL-RAR for Hemorrhoids
NCT04675177Phase 3Completed
- Sponsor
- University of Porto
- Start
- Sep 2019
- Primary completion
- Feb 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of 10XB101 in Hemorrhoids (2 arms), sponsored by University of Porto. Primary endpoints: Therapeutic success at 3 months and Safety evaluation at 3 months. Started Sep 2019; status: completed.
02
Drugs
10XB101
03
Conditions
Hemorrhoids
Beyond the preview
Go deeper on NCT04675177.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04675177.